Beijing Zhongke Ruiyi Information Technology Co., Ltd.

Established in 2020 and based in Beijing, China, CARE operates as a medical technology solution provider focusing on screening and diagnosing neurological diseases, which is incubated by the Chinese Academy of Sciences and cooperated with Peking Union Medical College Hospital. It has obtained certificates such as the National High-tech Research and Development Program (863 Program), National Key Research and Development Program Project Achievement Transformation Products, etc. In December 2024, the firm closed a series A+ funding. The company has formed four core product lines around two major directions: quantitative neurological function assessment and brain function intervention and reconstruction.

The company mainly provides a motor function evaluation system, intelligent eye movement analysis evaluation system, neurological function rehabilitation training system, and digital cognitive function evaluation system. The core products have been used in more than 100 top-tier tertiary hospitals, including Peking Union Medical College Hospital, Beijing Tiantan Hospital, and Beijing Xuanwu Hospital. The company’s revenue is generated by providing intelligent solutions for the full range of scenarios of screening, diagnosis, treatment and research of neurological diseases. The company will use the series A+ funding for product research and development, clinical trials, product registration and marketing promotion.